Sign In
Buy TRCK
$0.643
-0.0072 (-1.11%)
At Close: Jul 31, 2026
Acadia Gets FDA's Fast Track Tag for Alzheimer's Disease Candidate
11:50am, Tuesday, 21'st Jul 2026
ACAD wins FDA's Fast Track status for remlifanserin in Alzheimer's disease psychosis as its phase II data readout approaches and phase III enrollment advances.
Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis
09:05am, Monday, 20'th Jul 2026
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to remlifanserin, an investig
Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer
09:00am, Monday, 20'th Jul 2026
Designation supports development in an estimated $1 billion market where there are no FDA-approved therapies for patients whose disease progresses following first-line standard of care therapy Third F
Q2 Recap: Markets Get Back on Track
11:48am, Friday, 17'th Jul 2026
In financial markets, there is a concept known as “the wall of worry.” Put plainly, this concept describes how markets often see past short-term concerns to post positive returns, essentially clim
HawkEye 360 Proves Commercial Enabled Track Custody at Valiant Shield 2026
08:30am, Friday, 17'th Jul 2026
HERNDON, Va., July 17, 2026 /PRNewswire/ -- HawkEye 360, Inc. (NYSE: HAWK) the global leader in signals intelligence data and analytics, today announced its successful participation alongside Lockheed
Beamr Launches Blueprint: Fast Track to ML-Safe Compression for Autonomous Vehicle Teams
09:00am, Thursday, 16'th Jul 2026
In Blueprint, Beamr video data experts test compression on autonomous vehicle team's own models and workflows, delivering a verified plan built for their stack. A global autonomous vehicle program has
Is Lilly Stock On Track To Hit $2,090?
10:30am, Tuesday, 14'th Jul 2026
This article was written by Doug Nathman, with research by his team at Trefis.
Wesdome Announces Second Quarter 2026 Production Results; On Track to Achieve Full-Year Consolidated Production Guidance
05:05pm, Monday, 13'th Jul 2026
Toronto, Ontario--(Newsfile Corp. - July 13, 2026) - Wesdome Gold Mines Ltd. (TSX: WDO) (OTCQX: WDOFF) ("Wesdome" or the "Company") today announces its production results for the three and six months
MIAMI, July 13, 2026 /PRNewswire/ -- Starwood Capital Group ("Starwood Capital"), a leading global private investment firm, today announced the promotion of Qahir Madhany to Head of Acquisitions, Amer
Q2 Recap: Markets Get Back on Track
12:23pm, Friday, 10'th Jul 2026
Summary Technology drove strong US returns. Emerging Markets lead global returns, despite negative Chinese returns.
Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
07:00am, Monday, 29'th Jun 2026
TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing novel therapies
Aya Gold & Silver: Growth Remains On Track Despite The Pullback
08:55am, Sunday, 28'th Jun 2026
Aya Gold & Silver is rated a 'buy' due to undervaluation and strong growth prospects from its Moroccan assets. Zgounder remains a high-grade, low-cost silver mine with growing reserves, generating rob
Bunker Hill Mining on Track for Concentrate Production by the End of the Month
06:15am, Thursday, 25'th Jun 2026
KELLOGG, Idaho and VANCOUVER, British Columbia, June 25, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX: BNKR | OTCQB: BHLL) is pleased to provide an u
Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome
08:30am, Tuesday, 23'rd Jun 2026
QRX003 Holds Orphan Drug Designation in the United States, the European Union, and Japan, Plus Fast Track and Rare Pediatric Disease Designations from the FDA Pivotal Phase 3 Study Expected to Initiat
Delivers Letter to SMHI Board Highlighting Severe Discount to NAV, Which Has a Broker-appraised Value of Greater than $20 per Share Outlines Sequential Strategy to Unlock Value for Shareholders BLOOMF
